COMPARATIVE STUDY OF PORT SITE INFILTRATION AND INTRA-PERITONEAL INJECTION OF BUPIVACAINE VERSUS CONVENTIONAL ANALGESICS IN POST-OPERATIVE PAIN CONTROL FOLLOWING LAPAROSCOPIC SURGERIES

Abstract

Introduction: Pain management is critical for patients undergoing laparoscopic surgery, particularly laparoscopic cholecystectomy, which can induce pain from multiple sources including incision sites, deep abdomen, and shoulder irritation..

Methods: The study spanned from January 2023 to March 2024 at SMCH, involving 40 patients. Data collected included patient demographics, surgical details, duration, hospital stay, and pain assessment using Visual Analogue Scale (VAS).

Results: Patients receiving port site and intra-peritoneal bupivacaine infiltration (Group A) exhibited a mean hospital stay of 2.55 ± 0.51 days, compared to 2.5 ± 0.51 days in those receiving conventional analgesics (Group B). Early mobilization rates were higher in Group A (55.0%) compared to Group B (45.0%). Pain scores, although similar initially, trended favorably for bupivacaine infiltration, aligning with prior studies on intraperitoneal bupivacaine efficacy.

Conclusion: Port site and intra-peritoneal bupivacaine infiltration show promise in reducing post-surgical pain following laparoscopic surgery. However, further research is essential to establish their definitive superiority over conventional analgesics.